PedAM
Pediatric Disease Annotations & Medicines
| Disease | pulmonary hypertension |
| Symptom | C0024115|pulmonary disease |
| Sentences | 29 |
| PubMedID- 26492415 | Background: patients with severe pulmonary hypertension (ph) associated with chronic obstructive pulmonary disease (copd) present a poor outcome. |
| PubMedID- 22059898 | At admission, the boy already had complications—chronic pulmonary disease with pulmonary hypertension, and consequential myocardiopathy, hepatosplenomegaly, lymphadenopathy, autoimmune phenomena, malabsorption, growth retardation, and failure to thrive. |
| PubMedID- 26453478 | Potential role of ct metrics in chronic obstructive pulmonary disease with pulmonary hypertension. |
| PubMedID- 21393985 | The objective of this study was to investigate the associations among clinical, impedance cardiography, echocardiography, and chest roentgenography data in diagnosis of pulmonary hypertension for patients with cardiovascular and pulmonary diseases. |
| PubMedID- 25225149 | Pulmonary artery size as a predictor of pulmonary hypertension and outcomes in patients with chronic obstructive pulmonary disease. |
| PubMedID- 25922708 | Therapy in stable chronic obstructive pulmonary disease patients with pulmonary hypertension: a systematic review and meta-analysis. |
| PubMedID- 22333502 | The relationship between inflammatory mediators and pulmonary hypertension in patients with chronic obstructive pulmonary disease. |
| PubMedID- 26064044 | Aim: the aim of the current study is to evaluate acute vasoreactivity test (avt) results in severe pulmonary hypertension patients with chronic obstructive pulmonary disease and to compare the demographical, clinical, and laboratory variables in positive and negative cases. |
| PubMedID- 20819757 | The incidence and clinical course of pulmonary hypertension associated with chronic obstructive pulmonary disease is best known among the pulmonary hypertension associated with lung diseases. |
| PubMedID- 25469102 | Quantitative computed tomography of pulmonary emphysema and ventricular function in chronic obstructive pulmonary disease patients with pulmonary hypertension. |
| PubMedID- 22839713 | Association of parameters of heart rate variability with severity of bronchial obstruction and presence of pulmonary hypertension in patients with chronic obstructive pulmonary disease. |
| PubMedID- 25050435 | Aims: we aimed to assess the relationship between right ventricle (rv) dysfunction parameters and the soluble il-1 receptor family member (sst2) in patients with secondary pulmonary hypertension owing tochronic obstructive pulmonary disease. |
| PubMedID- 20364612 | pulmonary hypertension associated with chronic obstructive pulmonary disease. |
| PubMedID- 24228853 | Role of vasoactive intestinal peptide in chronic obstructive pulmonary disease with pulmonary hypertension. |
| PubMedID- 25176971 | The loss of pulmonary vessels has been shown to be related to the severity of pulmonary hypertension in patients with chronic obstructive pulmonary disease (copd). |
| PubMedID- 23549775 | This case study presents a 44-year old man with chronic obstructive pulmonary disease and “out of proportion” pulmonary hypertension. |
| PubMedID- 26277885 | Background: there is no recommendation for treating pulmonary hypertension (ph) when associated with chronic obstructive pulmonary disease (copd). |
| PubMedID- 25708588 | Cigarette smoking contributes to the development of pulmonary hypertension (ph) complicated with chronic obstructive pulmonary disease (copd), and the pulmonary vascular remodeling, the structural basis of ph, could be attributed to abnormal proliferation of pulmonary artery smooth muscle cells (pasmcs).in this study, morphometrical analysis showed that the pulmonary vessel wall thickness in smoker group and copd group was significantly greater than in nonsmokers. |
| PubMedID- 23855769 | Adenosine a2b receptor and hyaluronan modulate pulmonary hypertension associated with chronic obstructive pulmonary disease. |
| PubMedID- 26336405 | Of the patients who were not qualified for the study, 10 had aortic stenosis, 4 suffered from alcoholism, 6 neoplastic disease, 11 chronic obturative pulmonary disease with pulmonary hypertension, 9 diabetes mellitus, and 10 active myocarditis according to the dallas classification. |
| PubMedID- 26539466 | In group (2) chronic obstructive pulmonary disease with pulmonary hypertension (copd-ph) patients (n = 22), copd were diagnosed by pulmonologist and estimated mean pap ≥ 25 mmhg by echocardiography. |
| PubMedID- 21575307 | Background: chronic obstructive pulmonary disease (copd) can lead to pulmonary hypertension and cor pulmonale, which are predictors of mortality. |
| PubMedID- 26304628 | Inhibition of hmg-coa reductase (3-hydroxy-3-methyl-glutaryl-coa) by statins is an established treatment for the prevention of cardiovascular disease, and has recently been found to improve exercise capacity in chronic obstructive pulmonary disease patients with pulmonary hypertension 25. the mechanisms might include a beneficial effect on nitric oxide 26,27 and inhibition of endothelin 25. here, we show that simvastatin can impair the increase in dietary-induced pulmonary fibrosis, an affect clearly not related to either a decrease in plasma cholesterol or homocysteine, indicative of the pleiotropic role of simvastatin therapy. |
| PubMedID- 24578830 | Background: since pulmonary hypertension (ph) in patients with chronic obstructive pulmonary diseases (copd) causes poor prognosis and inflammatory process involved in ph, it is supposed that statins with anti-inflammatory effects might be useful in the treatment of ph. |
| PubMedID- 24015329 | in a recent study, eight patients with pulmonary hypertension associated with chronic obstructive pulmonary disease were daily treated with 200 mg of dhea. |
| PubMedID- 22307907 | Many chronic pulmonary diseases are associated with pulmonary hypertension (ph) and pulmonary vascular remodeling, which is a term that continues to be used to describe a wide spectrum of vascular abnormalities. |
| PubMedID- 25774911 | pulmonary hypertension (ph) is associated with several cardiopulmonary diseases that are prevalent among elderly patients . |
| PubMedID- 26064454 | Acute effects of riociguat in borderline or manifest pulmonary hypertension associated with chronic obstructive pulmonary disease. |
| PubMedID- 22461045 | Background: the speckle tracking echocardiography (ste) method shows the presence of right ventricular (rv) dysfunction before the advent of rv failure and pulmonary hypertension in patients with cardiopulmonary disease. |
Page: 1